New Delhi: Despite the neglect of trials to facilitate the availability of imported covid vaccines in India, Pfizer US drug makers have not made applications that are looking for authorization of emergency use because the talks on the neglect of compensation remains inconclusive.
The drug regulator has also asked the company in writing to apply for approval so that the application is processed well on time but the Pfizer does not apply to the license, the source said.
However, the problem of compensation not only holds Jab from Pfizer but other companies such as Modera and J & J are also seeking release from legal responsibility if there is a severe adverse reaction between vaccine recipients.
The conversation is currently underway at the government-to-government level between America and India.
While the government believes that it is trying to develop a mechanism, such benefits if permitted must be extended to all companies, regardless of foreign or local companies.